Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Docosahexaenoic acid (DHA) is vital for brain development and function, with deficiencies linked to neurodegenerative diseases like Alzheimer's and Parkinson's.
• Efficient transport of DHA across the blood-brain barrier is crucial for maintaining brain health.
• Lyso-phosphatidylcholine esterified with DHA at the sn-2 position enhances blood-brain barrier transport.

Purpose of the Study:

• To evaluate AceDoPC (1-acetyl,2-docosahexaenoyl-glycerophosphocholine) as a targeted delivery system for DHA to the brain.
• To compare the brain-targeting efficiency of AceDoPC with other DHA forms, including DHA-containing phosphatidylcholine (PC) and non-esterified DHA.
• To investigate the neuroprotective potential of AceDoPC in neurological conditions.

Main Methods:

• In vitro and in vivo experiments were conducted to assess DHA delivery.
• Ex vivo autoradiography was used to visualize DHA localization in rat brain regions.
• Molecular modeling was employed to analyze the surface properties of AceDoPC and lysoPC-DHA.

Main Results:

• AceDoPC demonstrated privileged and specific delivery of DHA to the brain compared to DHA-PC and non-esterified DHA.
• AceDoPC was partially hydrolyzed to lysoPC-DHA, the physiologically preferred form for brain transport.
• DHA from AceDoPC localized to brain regions critical for memory, thought, and cognition.

Conclusions:

• AceDoPC is identified as a highly efficient and specific carrier for delivering DHA to the brain.
• The structural similarity of AceDoPC to lysoPC-DHA contributes to its effective brain targeting.
• AceDoPC presents a promising strategy for potential preventive and therapeutic interventions in neurological diseases.